InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,307.01
(
-0.27%
)
US TECH 100
18,393.60
(
0.91%
)
Dow Jones
39,671.04
(
-0.51%
)
Brent Oil
82.32
(
0.96%
)
Bitcoin
69,716.37
(
0.89%
)
Post# of 80490
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

DonShimoda

Send PM Follow Ignore
Followers 19
Posts 727
Boards Moderated 0
Alias Born 11/10/2009

DonShimoda

Re: NP1986 post# 12863

Monday, 09/26/2011 9:46:40 AM

Monday, September 26, 2011 9:46:40 AM

Post# of 80490
I'll have to go back and check to be sure, but, I believe Sprycel's MCyr was in the low 60% and Tasigna upper 50% (not sure if this was 12 or 24 months). Considering Ponatinib achieved 72% in what is arguably a more heavily pre-treated patient population is certainly impressive.
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up